The potential anticancer activity of isorhamnetin seems to also be mediated by the effective reduction in interleukin 8 production by cancer cells, whose elevated level is linked to cancer progression and metastasis through its functions as a factor that triggers cell division or accelerates mitosis, migration and angiogenesis. This evidence concerns the gene CXCL8 and cancer.